Perbedaan Organon Pharma Indonesia Tbk. dan Surya Semesta Internusa Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Surya Semesta Internusa Tbk. diperdagangkan di Rp1.695 (kapitalisasi pasar 8,23 T, volume 24 jam 25,63 jt). Perbedaan utamanya: Surya Semesta Internusa Tbk. jauh lebih besar — sekitar 78,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SSIA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 8,23 T |
Volume | — | 25,63 jt |
Lot | — | 256,3 rb |
Perputaran | — | 43,66 M |
Harga Rata-rata | — | 1.703,42 |
Nilai Transaksi | — | 43,66 M |
Harga Ekuilibrium Indikatif | — | 1.695 |
Volume Ekuilibrium Indikatif | — | 2,72 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT. Surya Semesta Internusa Tbk (formerly known as PT. Multi Investment Ltd.) was established based on notarial deed No. 37 dated June 15, 1971 of Umi Sutamto, S.H., notary in Jakarta. It is a publicly-listed company engaged in investment in the shares of subsidiaries that develop and manage industrial and real estate, provide construction services, manufacture and market pre-cast and pre-stressed concrete and own hotels.
Selengkapnya di halaman SSIA →